DE60238395D1 - Ess-protein und verfahren zur verwendung davon - Google Patents
Ess-protein und verfahren zur verwendung davonInfo
- Publication number
- DE60238395D1 DE60238395D1 DE60238395T DE60238395T DE60238395D1 DE 60238395 D1 DE60238395 D1 DE 60238395D1 DE 60238395 T DE60238395 T DE 60238395T DE 60238395 T DE60238395 T DE 60238395T DE 60238395 D1 DE60238395 D1 DE 60238395D1
- Authority
- DE
- Germany
- Prior art keywords
- provides
- hairless protein
- ribozymes
- antisense oligonucleotides
- dnazymes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 108020000948 Antisense Oligonucleotides Proteins 0.000 abstract 2
- 102000053642 Catalytic RNA Human genes 0.000 abstract 2
- 108090000994 Catalytic RNA Proteins 0.000 abstract 2
- 108091027757 Deoxyribozyme Proteins 0.000 abstract 2
- 239000000074 antisense oligonucleotide Substances 0.000 abstract 2
- 238000012230 antisense oligonucleotides Methods 0.000 abstract 2
- 108020004999 messenger RNA Proteins 0.000 abstract 2
- 108091092562 ribozyme Proteins 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28361801P | 2001-04-13 | 2001-04-13 | |
| PCT/US2002/011683 WO2002083891A2 (en) | 2001-04-13 | 2002-04-12 | Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60238395D1 true DE60238395D1 (de) | 2011-01-05 |
Family
ID=23086858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60238395T Expired - Lifetime DE60238395D1 (de) | 2001-04-13 | 2002-04-12 | Ess-protein und verfahren zur verwendung davon |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US7423022B2 (de) |
| EP (2) | EP1385948B1 (de) |
| JP (1) | JP2005510204A (de) |
| AT (1) | ATE489466T1 (de) |
| DE (1) | DE60238395D1 (de) |
| WO (1) | WO2002083891A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE489466T1 (de) * | 2001-04-13 | 2010-12-15 | Univ Columbia | Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon |
| US20050233996A1 (en) * | 2002-02-20 | 2005-10-20 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA) |
| AU2004231740A1 (en) * | 2003-04-17 | 2004-11-04 | The Trustees Of Columbia University In The City Ofnew York | Desmoglein 4 is a novel gene involved in hair growth |
| US8168600B2 (en) | 2004-04-23 | 2012-05-01 | Isis Pharmaceuticals, Inc. | Compositions and methods for topical delivery of oligonucleotides |
| WO2005105157A2 (en) | 2004-04-23 | 2005-11-10 | The Trustees Of Columbia University In The City Ofnew York | INHIBITION OF HAIRLESS PROTEIN mRNA |
| DE102004025881A1 (de) * | 2004-05-19 | 2006-01-05 | Beiersdorf Ag | Oligoribonukleotide zur Beeinflussung des Haarwachstums |
| US8568797B2 (en) * | 2011-09-13 | 2013-10-29 | Avon Products, Inc | Method for enhancing the growth and fullness of hair |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US283618A (en) | 1883-08-21 | la mont | ||
| CA2362320A1 (en) * | 1998-01-29 | 1999-08-05 | The Trustees Of Columbia University In The City Of New York | Human hairless gene, protein and uses thereof |
| US6348348B1 (en) * | 1998-04-07 | 2002-02-19 | The Carnegie Institution Of Washington | Human hairless gene and protein |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| ATE489466T1 (de) * | 2001-04-13 | 2010-12-15 | Univ Columbia | Nukleinsäuren zur hemmung der expression von hairless-protein und verfahren zur verwendung davon |
-
2002
- 2002-04-12 AT AT02736569T patent/ATE489466T1/de not_active IP Right Cessation
- 2002-04-12 JP JP2002582229A patent/JP2005510204A/ja active Pending
- 2002-04-12 DE DE60238395T patent/DE60238395D1/de not_active Expired - Lifetime
- 2002-04-12 EP EP02736569A patent/EP1385948B1/de not_active Expired - Lifetime
- 2002-04-12 US US10/122,013 patent/US7423022B2/en not_active Expired - Fee Related
- 2002-04-12 EP EP10184165A patent/EP2327784A3/de not_active Withdrawn
- 2002-04-12 WO PCT/US2002/011683 patent/WO2002083891A2/en active Application Filing
-
2008
- 2008-06-16 US US12/139,818 patent/US20090004169A1/en not_active Abandoned
-
2010
- 2010-03-01 US US12/715,207 patent/US8008471B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002083891A2 (en) | 2002-10-24 |
| EP1385948A4 (de) | 2005-07-20 |
| JP2005510204A (ja) | 2005-04-21 |
| ATE489466T1 (de) | 2010-12-15 |
| US8008471B2 (en) | 2011-08-30 |
| US7423022B2 (en) | 2008-09-09 |
| US20100221318A1 (en) | 2010-09-02 |
| EP1385948B1 (de) | 2010-11-24 |
| US20090004169A1 (en) | 2009-01-01 |
| WO2002083891A3 (en) | 2002-12-12 |
| US20030077614A1 (en) | 2003-04-24 |
| EP2327784A3 (de) | 2012-11-28 |
| EP2327784A2 (de) | 2011-06-01 |
| EP1385948A2 (de) | 2004-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL173348A (en) | Thienopyridine compounds, pharmaceuticals containing them and their use in the preparation of drugs | |
| ATE369894T1 (de) | Kombination enthaltend ein mittel zur verminderung von vegf-aktivität und ein mittel zur verminderung von egf-aktivität | |
| DE60143360D1 (de) | Zusammensetzung zur transdermalen und/oder transmukosalen Verabreichung von Wirkstoffen, die ausreichende therapeutische Spiegel garantiert | |
| IL138476A0 (en) | Method for treating pharmaceutical compositions by special use of anti-oxidant | |
| WO2001044247A3 (en) | Agents and methods for the treatment of proliferative diseases | |
| ATE358669T1 (de) | Pyrazolderivate zur behandlung von hiv | |
| CY1107640T1 (el) | Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη | |
| DE60134021D1 (de) | Pharmazeutische zubereitungen zur angiogenese-therapie | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| ATE345681T1 (de) | Verfahren zur herstellung von antimikrobiellen parfümierenden zusammensetzungen | |
| CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
| DE60238395D1 (de) | Ess-protein und verfahren zur verwendung davon | |
| DE60136748D1 (de) | Verfahren und zusammensetzungen zur behandlung von augenerkrankungen | |
| RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
| DE50114605D1 (de) | No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
| ATE359816T1 (de) | Verfahren zur prävention und behandlung von infektionen mit dem flavivirus bei tieren | |
| HUP0402327A2 (hu) | Inzulinszerű növekedési faktort kötő 5-ös fehérje expressziójának antiszensz módosítása | |
| DE60134234D1 (de) | Nukleinsäurekonstrukte, damit transformierte vaskuläre zellen, pharmezeutische zusammensetzungen und verfahren zur induktion der angiogenese | |
| DE60333747D1 (de) | Dna-enzym zur hemmung von plasminogenaktivator-inhibitor-1 | |
| BRPI0411168B1 (pt) | Composição para o tratamento dos cabelos, usos da composição e método de tratamento dos cabelos. | |
| WO2001044235A3 (en) | Agents and methods for the treatment of proliferative diseases | |
| DE50205026D1 (de) | Verfahren zur herstellung von n-substituierten 2,6-dialkylmorpholinen | |
| DE60229047D1 (de) | Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit | |
| DE602004016547D1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
| ATE340576T1 (de) | Wirkstoff-kombination zur medikamentösen therapie der nikotinabhängigkeit |